European Association for the Study of Diabetes

European Association for the Study of Diabetes Promoting excellence in diabetes care since 1965. The European Association for the Study of Diabetes e.V.
(1)

(EASD) is a membership-based academic non-profit organization. It was founded in 1965 and its headquarters is based in Duesseldorf, Germany. EASD is a networks for diabetologists with active members from all over the world. Membership is open to scientists, physicians, students, postdocs and fellows, allied health professionals and nurses who are interested in the field of diabetes or related diseases. The EASD Annual Meeting is one of the largest diabetes conferences in the world, attracting thousands of delegates each year. The scientific programme includes hundreds of talks, presentations and discussions on the latest results from basic and clinical diabetes research. EASD is also a leading player in postgraduate education having trained thousands of healthcare professionals through dedicated training courses and online education activities. Our award winning e-Learning platform, offers free access to courses developed with world-class experts in diabetes research and care. The Association is actively involved in producing and endorsing statements and guidelines translating the latest results from diabetes research into best practices in diabetes management. These statements and guidelines have proven to have significant visibility and substantial impact on health care, particularly when concerning statements on treatment and diagnostic criteria. By creating the Early Career Academy, EASD has increased its commitment to support, train, mentor, and create opportunities for scientists, clinicians, and students who are at an early or intermediate stage of their career. The European Foundation for the Study of Diabetes (EFSD) was founded by EASD in 2000 to stimulate diabetes research in Europe. EFSD offers support in all areas of diabetes research through a wide range of joint and stand-alone initiatives. Funding streams are available throughout the year and since inception, EFSD has committed over €120 million to diabetes research in Europe. EASD is also the publisher of Diabetologia, a major monthly international diabetes journal with an impact factor of 8.2 (2022). The journal publishes original clinical, translational and experimental research on all aspects of diabetes and related subjects. For more information about EASD, please visit: www.easd.org

✨ Today, we’re celebrating International Day of Education. This day reminds us of education's vital role in building pea...
24/01/2026

✨ Today, we’re celebrating International Day of Education.
This day reminds us of education's vital role in building peace and advancing sustainable development worldwide. Education is not only a pathway to knowledge but also a fundamental human right, a public good and our collective responsibility.
At EASD, we're proud to promote education in diabetes research and care. From our free e-Learning platform and hands-on training to expert workshops and global collaborations. We’re committed to educate and inspire researchers and healthcare professionals at every career stage by covering both practical and emerging topics in diabetes and related fields.
Explore more on EASD e-Learning 📖👉 https://easd-elearning.eu/home/

📢🫵 We still want to hear from you! The EASD Guidelines Oversight Committee (GOC) invites all EASD members to help shape ...
23/01/2026

📢🫵 We still want to hear from you!

The EASD Guidelines Oversight Committee (GOC) invites all EASD members to help shape the future of diabetes care by suggesting topics for upcoming clinical practice guidelines.

Your expertise and experience are invaluable in identifying areas where evidence-based guidance is most needed and will directly influence our future guideline priorities.

🗓️ Please complete the survey by 9 February 2026.
Propose your topic here 🔗👉 https://www.surveymonkey.com/r/K6LBPNT

📢🫵 Call for input - we want to hear from you!

The European Association for the Study of Diabetes (EASD) Guidelines Oversight Committee (GOC) invites all EASD members to help shape the future of diabetes care by suggesting topics for upcoming clinical practice guidelines.

Your expertise and experience are invaluable in identifying areas where evidence-based guidance is most needed and will directly influence our future guideline priorities.

🗓️ Please complete the survey by 9 February 2026.

🔗👉 https://www.surveymonkey.com/r/K6LBPNT

🎙️ New Podcast Episode | Diabetes Insights🍽️ 🕰️ When, how, and what we eat. Does timing really matter for metabolism and...
23/01/2026

🎙️ New Podcast Episode | Diabetes Insights

🍽️ 🕰️ When, how, and what we eat. Does timing really matter for metabolism and diabetes?

In this episode, we speak with Prof. Frederic Gachon (Aarhus Universitet) and Prof. Dr. Olga Ramich (German Institute of Human Nutrition and Charité - Universitätsmedizin Berlin) about the emerging science of circadian rhythms, meal timing, and exercise in metabolic health.

From chronotype and late-night eating to intermittent fasting and the timing of physical activity, the conversation explores how aligning daily behaviours with our internal clocks may improve insulin sensitivity, weight regulation, and overall metabolic outcomes.

🎧 Listen now: https://www.easd.org/media-centre/podcasts/

🏆 Nominate a deserving colleague for the 41st EASD Camillo Golgi Prize! The Camillo Golgi Prize recognises exceptional c...
22/01/2026

🏆 Nominate a deserving colleague for the 41st EASD Camillo Golgi Prize!

The Camillo Golgi Prize recognises exceptional contributions to the histopathology, pathogenesis, prevention, and treatment of diabetes complications and comorbidities. The prize recipient will deliver a lecture at the EASD Annual Meeting 2026, where the awardee will present their major scientific achievements.

To be eligible for nomination:
✅ Candidates must be an EASD member
✅ Candidates can be from any country
✅ There are no age restrictions

📅 Deadline: 15 February 2026 | 🕛 12:00 CET

Nominate a deserving colleague at https://www.easd.org/prizes/camillo-golgi/

Prize generously supported by Novo Nordisk

📢 Just 2 weeks left to apply for the   and Novo Nordisk A/S Programme for Diabetes Research in Europe! Researchers acros...
22/01/2026

📢 Just 2 weeks left to apply for the and Novo Nordisk A/S Programme for Diabetes Research in Europe! Researchers across all fields of diabetes research, from basic science to clinical studies, are invited to apply.

🗓 Application Deadline: 2 February 2026 | 🕛12:00 CET

Learn more and apply via the EFSD Programme Portal ➡️ https://www.europeandiabetesfoundation.org/programmes/programme-calls/efsd-and-novo-nordisk-as-programme-for-diabetes-research-in-europe-call/

🔬 Applications are now open for the and A/S Programme for Diabetes Research in Europe! The programme welcomes applications from researchers at non-profit institutions in Europe and associated countries working on innovative diabetes research projects.

📅 Application Deadline: 2 February 2026

Learn more and submit your application via the EFSD Programme Portal 👉 https://www.europeandiabetesfoundation.org/programmes/programme-calls/efsd-and-novo-nordisk-as-programme-for-diabetes-research-in-europe-call/

Prize supported by Novo Nordisk.

21/01/2026

🧬 What if beta cells are more diverse than we thought?

➡️ In this new EASD e-Learning Expert Insights episode, epigenetics expert Professor J. Andrew Pospisilik introduces a major shift in how we understand beta cell function and disease heterogeneity. He touches on:

🎯 The role of epigenetics in shaping beta cell identity
🎯 How epigenetics determine differing obesity endotypes
🎯 Using your clinical intuition to unlock research breakthroughs

📺 Watch the episode now on the EASD e-Learning platform:

🔗 https://easd-elearning.eu/episode/359/The-epigenetics-of-beta-cell-failure.html

📢 We are pleased to announce that applications are open for the 29th EASD Oxford Workshop 2026, hosted at Keble College,...
21/01/2026

📢 We are pleased to announce that applications are open for the 29th EASD Oxford Workshop 2026, hosted at Keble College, Oxford, UK.

This prestigious and highly interactive workshop will focus on organ crosstalk in metabolic regulation and diabetes and brings together around 40 leading experts and a small number of selected early-career scientists or clinicians for in-depth scientific exchange and collaboration.

This workshop is open to early-career researchers or clinicians with a strong background in biomedical sciences, life sciences, biochemistry, medicine, or related fields, and demonstrated expertise relevant to the workshop topic.

📅 Application deadline: 20 February 2026
⚠️ Please note: Limited places available – early application is strongly encouraged

Learn more & apply 👉 https://www.easd.org/education/meetings-and-courses/oxford-workshop/oxford-workshop-2026/

🧠 Meet Asst. Prof. Miriam Longo (Università degli Studi Link) recipient of the EASD Albert Renold Travel Fellowship - su...
20/01/2026

🧠 Meet Asst. Prof. Miriam Longo (Università degli Studi Link) recipient of the EASD Albert Renold Travel Fellowship - supporting scientists and clinicians in traveling to other institutions to learn specialized techniques or clinical skills needed for their diabetes research.

Her fellowship advanced metabolic research through training in gold-standard glycaemic clamp techniques and investigation of the gut-brain axis. At the Center for Clinical Metabolic Research, Dr. Longo gained expertise in euglycaemic and hypoglycaemic clamps and contributed to the GUTBBB study on gut integrity, inflammation, blood-brain barrier function, and cognitive dysfunction in obesity.

🗣️ Reflecting on the fellowship, Dr. Longo shares: “Being an EFSD fellow provided me with advanced training in gold-standard metabolic techniques and strengthened my focus on the relationship between the brain and metabolic diseases, which has always been a central theme of my research aspirations. It also offered the opportunity to participate in an international collaborative project. This fellowship has been instrumental in shaping my scientific career, opening new research directions, and fostering long-term collaborations.”

📖 Read the related publication: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(23)00449-7/fulltext

💡 Explore EFSD programmes: https://www.europeandiabetesfoundation.org/programmes/

⏰ Don’t miss the EASD Early Career Academy's first webinar of 2026! Join Prof. Christian Herder as he explores how infla...
20/01/2026

⏰ Don’t miss the EASD Early Career Academy's first webinar of 2026! Join Prof. Christian Herder as he explores how inflammatory biomarkers can identify (pre)diabetes subtypes, refine risk & guide personalised prevention & treatment.

📅 29 Jan 2026 | 🕛 16:00 CET

🔗👉 Register now: https://us06web.zoom.us/webinar/register/WN_qSgsxFL4R7aoRxqlpmrFKA #/registration

Join the EASD Early Career Academy’s first webinar of the year with Prof. Christian Herder (German Diabetes Center and Heinrich-Heine-Universität Düsseldorf) who will be sharing insights on how novel inflammatory markers are reshaping our understanding of diabetes heterogeneity.

Don't miss this opportunity to learn about the latest advances in biomarker research and their clinical applications in diabetes prevention and treatment.

📅 29 January 2026 | 🕛 16:00 CET

🔗👉 Register now: https://us06web.zoom.us/webinar/register/WN_qSgsxFL4R7aoRxqlpmrFKA #/registration

🏆 Nominate an outstanding early career scientist for the EASD Minkowski Prize 2026! This prestigious award recognises ex...
19/01/2026

🏆 Nominate an outstanding early career scientist for the EASD Minkowski Prize 2026! This prestigious award recognises excellent research by early career scientists advancing our understanding of diabetes mellitus.

Eligibility:
✅ Open to EASD members worldwide
✅ Under 45 years of age OR PhD/MD within the last 15 years (extensions considered for exceptional circumstances)
✅ Demonstrated significant contributions to diabetes research

📅 Deadline: 15 February 2026 | 🕛12:00 CET

👉 More details: https://www.easd.org/prizes/minkowski.html

Prize recipient will deliver a lecture at the Annual Meeting in Milan, describing their most important scientific achievements.

Prize generously supported by Lilly Diabetes International.

🎧🎙️Weekend listening recommendation: SURPASS CVOT Trial Results!The latest episode of the EASD podcast dives into the SU...
16/01/2026

🎧🎙️Weekend listening recommendation: SURPASS CVOT Trial Results!

The latest episode of the EASD podcast dives into the SURPASS CVOT trial, a landmark study comparing tirzepatide to dulaglutide in over 13,000 people with type 2 diabetes.

Prof. Tina Vilsbøll and Prof. Hertzel Gerstein discuss how this trial confirms cardioprotective efficacy, informs personalised diabetes care, and highlights the power of collaboration between diabetologists, cardiologists, and other specialists.

Learn how these outcomes are shaping future guidelines and improving patient care.

👉 Listen now: https://www.easd.org/media-centre/podcasts.html

📢 The moment you've been waiting for is here: Abstract submissions for the 62nd EASD Annual Meeting are officially open!...
16/01/2026

📢 The moment you've been waiting for is here: Abstract submissions for the 62nd EASD Annual Meeting are officially open! Share your groundbreaking diabetes research with the global community in Milan, Italy from 28 September - 02 October 2026.

🗓️ Submission deadline: 1 April 2026 | 🕛 18:00 CEST

Start preparing your submission today and stay tuned for more reminders as the deadline approaches - we want to hear from you!

📝 All abstracts must be submitted online via MyEASD. Learn more and submit here: https://www.easd.org/annual-meeting/easd-2026/scientific-submissions/

Adresse

EASD/Rheindorfer Weg 3
Düsseldorf
40591

Öffnungszeiten

Montag 08:00 - 17:00
Dienstag 08:00 - 17:00
Mittwoch 08:00 - 17:00
Donnerstag 08:00 - 17:00
Freitag 08:00 - 17:00

Telefon

+492117584690

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von European Association for the Study of Diabetes erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an European Association for the Study of Diabetes senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The Active Membership of the Association currently numbers more than 4,000 individuals from over 100 countries throughout the world. The Association also bestows Honorary Membership on any individual whose medical or scientific contribution to diabetes research has been outstanding; the first Honorary Member of the Association was Charles Best. The Association is governed by an Executive Committee chaired by the President. The Annual Meeting of the Association is held in a different European city each year. Abstracts are invited from members as well as non-members. All abstracts are anonymously reviewed by a Programme Committee, chaired by the Honorary Secretary. The EASD was one of the first international Associations to introduce the anonymous review of abstracts. The high quality of scientific research presented at the Annual Meetings is attested to by the increasing participation. The scientific programme of the Meeting, providing titles of the lectures and symposia, is made available online at a very early stage. Once confirmed, the speakers' names are made available and before the start of the Meeting all abstracts accepted for presentation can be accessed online. A search function assists the visitor in finding abstracts in their field of interest. Webcasts, poster presentations from the EASD Annual Meeting can be accessed via the EASD website.

EASD Postgraduate Education Courses have been organised by the Association since 1972 and, since then, over 25,000 medical professionals have taken part.

In 1999, the EASD increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD).

Since its inception, EFSD has committed over Euro 100 million to diabetes research in Europe by various funding means.